A Study of Ad26.COV2.S in Healthy Adults (COVID-19)
Clinical trial NCT04894305 · COMPLETED
Trial details
- NCT number
- NCT04894305
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-25
- Primary completion
- 2021-12-08
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.